New diagnostic and therapeutic tools
against multidrug resistant tumours

DRU Highlights

Our paper

The multi-factorial nature of clinical multidrug resistance in cancer

was selected by ASPIC (Portuguese Association of Cancer Research), to be highlighted on their website

 

Back to Events / News